Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?

E-ISSN： 1529-0131|48|10|2701-2705

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.48, Iss.10, 2003-10, pp. : 2701-2705

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2741-2749

John Wiley & Sons Inc

Access to resources Recommend Favorite

Will Pharmacogenetics Predict Response to Therapies in Rheumatoid Arthritis?

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-01 ,pp. : 307-319

Bentham Science Publishers

Access to resources Recommend Favorite

The development of novel therapies for rheumatoid arthritis

By Quan Ling-dong Thiele Geoffrey M Tian Jun Wang Dong

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 723-738

Informa Healthcare

Access to resources Recommend Favorite

Alcohol consumption and markers of inflammation in women with preclinical rheumatoid arthritis

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3554-3559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose/Exposure‐Response Modeling to Support Dosing Recommendation for Phase III Development of Baricitinib in Patients with Rheumatoid Arthritis

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 6, Iss. 12, 2017-12 ,pp. : 804-813

John Wiley & Sons Inc

Access to resources Recommend Favorite